miR-21对唾液腺腺样囊性癌细胞增殖和凋亡的影响及机制研究

doi:10.19438/j.cjoms.2017.03.004

中国口腔颌面外科杂志 ›› 2017, Vol. 15 ›› Issue (3): 209-213.doi: 10.19438/j.cjoms.2017.03.004

miR-21对唾液腺腺样囊性癌细胞增殖和凋亡的影响及机制研究

严斐¹，王超¹，黎婷¹，蔡文燕²，孙晋虎¹，²

1.徐州医科大学口腔医学院，江苏徐州 221000；
2.南京医科大学附属儿童医院口腔科，江苏南京 210000；
3.徐州医科大学附属医院口腔科，江苏徐州 221000

收稿日期:2016-10-11 修回日期:2017-01-12 出版日期:2017-05-20 发布日期:2017-06-09
通讯作者: 江苏省高校“青蓝工程”中青年学术带头人资助项目（51934）；徐州医学院优秀人才基金资助项目（2013012）
作者简介:严斐（1991-），女，硕士，E-mail:yffeifei@126.com
基金资助:
孙晋虎，E-mail: kqxsjh@163.com

Effect and underlying mechanism of miR-21 on proliferation and apoptosis of salivary adenoid cystic carcinoma cells

YAN Fei¹, WANG Chao¹, LI Ting¹, CAI Wen-yan², SUN Jin-hu¹，².

1.Department of Oral Medicine, School of Stomatology, Xuzhou Medical University. Xuzhou 221000；
2.Department of Stomatology, Children's Hospital Affiliated to Nanjing Medical University. Nanjing 210000；
3.Department of Stomatology, Affiliated Hospital of Xuzhou Medical University. Xuzhou 221004, Jiangsu Province, China

Received:2016-10-11 Revised:2017-01-12 Online:2017-05-20 Published:2017-06-09

摘要/Abstract

摘要： 目的：探讨miR-21对人唾液腺腺样囊性癌细胞株(SACC-LM)增殖、凋亡的影响及其相关作用机制。方法：将SACC-LM细胞分为 3 组，采用LipofectamineTM2000做瞬时转染。干扰组转染miR-21 inhibitor，阴性对照组转染无关核苷酸序列，空白对照组不转染。采用实时荧光定量PCR检测转染后细胞中miR-21和PDCD4、Bcl-2 mRNA的表达水平。以CCK8法检测转染24、48、72、96 h后细胞的增殖活性，Annexin-V/PI 双染色流式细胞术检测细胞凋亡率，Western免疫印迹检测转染后靶蛋白 PDCD4、Bcl-2的表达量。采用 SPSS 16.0软件包对所得数据进行统计学分析。结果：转染miR-21 inhibitor的细胞中miR-21、Bcl-2表达下调（P＜0.01），而PDCD4基因表达上调（P<0.05）。CCK8检测结果表明，miR-21表达下调可以明显抑制SACC-LM细胞的增殖活性，并呈时间依赖性（P<0.05）。流式细胞术检测结果表明，干扰组细胞凋亡率显著高于阴性对照组和空白组（P<0.05）；Western 免疫印迹结果显示， PDCD4蛋白的表达较对照组显著升高（P<0.01），Bcl-2蛋白表达显著降低（P<0.01）。结论：下调miR-21的表达可抑制SACC-LM细胞的增殖活性，诱导细胞凋亡，其机制可能与细胞内PDCD4表达上调，Bcl-2表达下调有关。

关键词: microRNA-21, 唾液腺腺样囊性癌, 增殖, 凋亡, PDCD4, Bcl-2

Abstract: PURPOSE: To investigate the effect and regulatory mechanisms of miR-21 on proliferation and apoptosis of human salivary adenoid cystic carcinoma (SACC-LM) cells. METHODS: SACC-LM cells were transfected with miR-21 inhibitor by LipofectamineTM 2000. Meanwhile, SACC-LM cells were transfected with NC inhibitor as negative control. Cell survival rate was calculated with CCK-8 assay at 24, 48, 72 and 96 h after transfection. The apoptosis rate was measured by flow cytometry. qRT-PCR analysis and Western blot were used to detect the expression of miR-21, PDCD4 and Bcl-2 in SACC-LM cell lines after transfection. SPSS 16.0 software package was used for statistical analysis. RESULTS: miR-21 expression was remarkably downregulated in miR-21 inhibitor-transfected cells. In the meantime, gene expression of PDCD4 was increased and Bcl-2 was decreased (P<0.05). miR-21 silencing triggered to a decreased cell viability in a time-dependent manner compared with the control groups (P<0.05). The apoptosis rate was dramatically increased compared with the control groups (P<0.01), and PDCD4 protein expression was significantly increased (P<0.05), while Bcl-2 was significantly decreased (P<0.05). CONCLUSIONS: Downregulation of miR-21 can inhibit proliferation of SACC-LM cells and induce apoptosis. The mechanism may be related to the increased expression of PDCD4 and decreased expression of Bcl-2.

Key words: miR-21, Salivary adenoid cystic carcinoma, Proliferation, Apoptosis, PDCD4, Bcl-2

中图分类号:

R739.8

严斐，王超，黎婷，蔡文燕，孙晋虎，. miR-21对唾液腺腺样囊性癌细胞增殖和凋亡的影响及机制研究[J]. 中国口腔颌面外科杂志, 2017, 15(3): 209-213.

YAN Fei, WANG Chao, LI Ting, CAI Wen-yan, SUN Jin-hu，.. Effect and underlying mechanism of miR-21 on proliferation and apoptosis of salivary adenoid cystic carcinoma cells[J]. China J Oral Maxillofac Surg, 2017, 15(3): 209-213.

参考文献

[1] 蔡文燕, 严斐, 董晶, 等辛伐他汀对唾液腺腺样囊性癌细胞生长及survivin 表达的影响[J]. 中国口腔颌面外科杂志, 2016, 14(3): 213-217.
[2] He Q, Zhou X, Li S, et al. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway [J]. Biochim Biophys Acta, 2013, 1830(11): 5258-5266.
[3] 张瑞智, 张萍, 余波, 等. siRNA 干扰 Mcl-1对唾液腺腺样囊性癌 SACC-2细胞生物活性的影响[J]. 实用口腔医学杂志, 2014, 30(6): 809-812.
[4] He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation [J]. Nat Rev Genet, 2004, 5(7):522-531.
[5] Yu Y, Kanwar SS, Patel BB, et al. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells [J]. Carcinogenesis, 2012, 33(1): 68-76.
[6] Ren QH, Liang JQ, Wei JJ, et al. Epithelial and stromal expression of miRNAs during prostate cancer progression [J]. Am J Transl Res, 2014, 6(4): 329-339.
[7] 潘文征, 唐万燕, 袁伟, 等. 微小 RNA 在胰腺癌患者血浆中的表达情况及临床意义[J]. 中华肿瘤杂志, 2014, 36(5): 351-354.
[8] Faltejskova P, Besse A, Sevcikova S, et al. Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells [J]. Int J Colorectal Dis, 2012, 27(11): 1401-1408.
[9] Ren Q, Liang J, Wei J, et al. Epithelial and stromal expression of miRNAs during prostate cancer progression [J]. Am J Transl Res, 2014, 6(4): 329-339.
[10] Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma [J]. Nature, 2010, 467(7311): 86-90.
[11] Zhang BG, Li JF, Yu BQ, et al. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN [J]. Oncol Rep, 2012, 27(4): 1019-1026.
[12] Peacock O, Lee AC, Cameron F, et al. Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancer [J]. PloS One, 2014, 9(10): e110267.
[13] Shi L, Chen J, Yang J, et al. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity [J]. Brain Res, 2010, 1352: 255-264.
[14] Li T, Li LC, Li DS, et al. MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor [J]. Int J Clin Exp Patho, 2015, 8(2): 1364-1373.
[15] Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes[J]. Oncogene, 2006, 25(46): 6188-6196.
[16] Najafi Z, Sharifi M, Javadi G. Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma [J]. Cancer Gene Ther, 2015, 22(11): 530-535.
[17] Jiang LH, Ge MH, Hou XX, et al. miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma [J]. Lab Invest, 2015, 95(12): 1398-1408.
[18] Saxena A, Shoeb M, Ramana KV, et al. Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression [J]. Eur J Cancer, 2013, 49(15): 3311-3319.
[19] 郭民英, 邢永川, 陈卫伶, 等. Bcl-2、p53和ki-67在甲状腺癌中的表达及其临床意义的研究[J]. 现代肿瘤医学, 2014, 22(6): 1294-1297.

miR-21对唾液腺腺样囊性癌细胞增殖和凋亡的影响及机制研究

Effect and underlying mechanism of miR-21 on proliferation and apoptosis of salivary adenoid cystic carcinoma cells

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈华, 李婧, 罗梅. 红景天甙通过NRF2/KEAP1通路对口腔鳞癌细胞生长的影响[J]. 中国口腔颌面外科杂志, 2024, 22(5): 424-429.
[2]	周鑫霞，刘敬浩，甘桂芳，陈福祥. 鞘氨醇-1-磷酸受体4在口腔鳞状细胞癌中的表达及生物学功能[J]. 中国口腔颌面外科杂志, 2024, 22(1): 10-15.
[3]	李华盛, 周迪, 韩楠男, 严明, 阮敏. 石蒜碱通过降解SCAP蛋白抑制口腔鳞癌细胞增殖与侵袭的实验研究[J]. 中国口腔颌面外科杂志, 2024, 22(1): 29-35.
[4]	林惠, 高云飞, 刘晶, 马旭辉. 槐角提取物对颌骨骨髓间充质干细胞成骨向分化的影响[J]. 中国口腔颌面外科杂志, 2024, 22(1): 73-77.
[5]	许贵松, 杨功鑫, 游元和, 田卓炜, 肖孟, 杜仲, 王延安. 20例面部先天性浸润性脂肪增殖症的临床及影像学分析[J]. 中国口腔颌面外科杂志, 2023, 21(5): 472-478.
[6]	慕家宁, 袁文清, 陆洲, 赵阳, 王奇民, 童磊, 陈正岗. Cdc42在舌鳞状细胞癌中的表达及其对细胞增殖、迁移、侵袭的影响[J]. 中国口腔颌面外科杂志, 2023, 21(3): 209-217.
[7]	赵婷婷, 冯艳青, 何倩婷, 莫云龙, 董恩恩, 王安训. ATIP1和ATIP3a对口腔恶性肿瘤细胞增殖和凋亡的影响[J]. 中国口腔颌面外科杂志, 2021, 19(5): 417-423.
[8]	郭铭, 陈羽菱, 吴利, 张璧茹, 沈月洪, 杨宏宇. SREBP2对口腔鳞癌细胞增殖和迁移的影响及其调控机制[J]. 中国口腔颌面外科杂志, 2021, 19(4): 295-301.
[9]	张莹, 吴利, 陈羽菱, 林云涛, 沈月洪, 杨宏宇. POLD1对口腔鳞癌细胞增殖、侵袭的影响及调控机制[J]. 中国口腔颌面外科杂志, 2021, 19(4): 302-308.
[10]	王越, 劳蔚, 孙宇. 丙泊酚对人咽鳞癌FADu细胞系增殖、迁移、侵袭和凋亡的调节作用[J]. 中国口腔颌面外科杂志, 2021, 19(3): 201-204.
[11]	陈正岗, 王奇民, 童磊, 王云英, 徐晓娜, 王莹, 韩红钰, 盛善桂, 王少如. 沉默Icmt基因对舌鳞癌CAL-27和SCC-4细胞增殖、凋亡及细胞周期的影响[J]. 中国口腔颌面外科杂志, 2021, 19(2): 97-104.
[12]	王子昱, 丁宇洁, 陈冰, 沈昊翀, 孟箭, 仝伟凤. α桐酸对舌鳞状细胞癌CAL-27细胞的体外抑制作用[J]. 中国口腔颌面外科杂志, 2020, 18(6): 490-494.
[13]	李捷, 陈巨峰, 冼淡. 巨噬细胞来源的白细胞介素6对口腔鳞癌细胞增殖活性的影响[J]. 中国口腔颌面外科杂志, 2019, 17(6): 503-507.
[14]	张意闻, 罗远, 郭华艳, 张迎娣, 缪国俊, 黄远亮. 淫羊藿次苷对犬颌骨间充质干细胞增殖与成骨分化的影响[J]. 中国口腔颌面外科杂志, 2019, 17(4): 304-310.
[15]	徐博雅, 杨子桧, 王珺, 雷德林, 杨新杰. CCL2和CCR2在唾液腺腺样囊性癌中的表达及意义[J]. 中国口腔颌面外科杂志, 2019, 17(4): 311-315.